Literature DB >> 7682137

Nitric oxide-mediated hyporeactivity to noradrenaline precedes the induction of nitric oxide synthase in endotoxin shock.

C Szabó1, J A Mitchell, C Thiemermann, J R Vane.   

Abstract

1. The role of an enhanced formation of nitric oxide (NO) and the relative importance of the constitutive and inducible NO synthase (NOS) for the development of immediate (within 60 min) and delayed (at 180 min) vascular hyporeactivity to noradrenaline was investigated in a model of circulatory shock induced by endotoxin (lipopolysaccharide; LPS) in the rat. 2. Male Wistar rats were anaesthetized and instrumented for the measurement of mean arterial blood pressure (MAP) and heart rate. In addition, the calcium-dependent and calcium-independent NOS activity was measured ex vivo by the conversion of [3H]-arginine to [3H]-citrulline in homogenates from several organs obtained from vehicle- and LPS-treated rats. 3. E. coli LPS (10 mg kg-1, i.v. bolus) caused a rapid (within 5 min) and sustained fall in MAP. At 30 and 60 min after LPS, pressor responses to noradrenaline (0.3, 1 or 3 micrograms kg-1, i.v.) were significantly reduced. The pressor responses were restored by NG-nitro-L-arginine methyl ester (L-NAME, 1 mg kg-1, i.v. at 60 min), a potent inhibitor of NO synthesis. In contrast, L-NAME did not potentiate the noradrenaline-induced pressor responses in control animals. 4. Dexamethasone (3 mg kg-1, i.v., 60 min prior to LPS), a potent inhibitor of the induction of NOS, did not alter initial MAP or pressor responses to noradrenaline in control rats, but significantly attenuated the LPS-induced fall in MAP at 15 to 60 min after LPS. Dexamethasone did not influence the development of the LPS-induced immediate (within 60 min) hyporeactivity to noradrenaline. However,dexamethasone pretreatment prevented the hypotension and vascular hyporeactivity at 180 min.5. At 60 min after LPS a moderate increase in the activity of a calcium-independent (inducible) NOS activity was detected in the aorta, but not in any of the other tissues studied. However, at 180 min after LPS, a significant NOS induction was observed in the lung, liver, spleen, mesentery, heart and aorta.This NOS induction was substantially prevented by pretreatment with dexamethasone.6. These results suggest that the immediate hypotension and vascular hyporeactivity to noradrenaline in endotoxin shock is caused by an enhanced formation of NO due to activation of the constitutive enzyme. The delayed hypotension and vascular hyporeactivity, however, is due to enhanced NO formation by the LPS-induced enzyme.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7682137      PMCID: PMC1908041          DOI: 10.1111/j.1476-5381.1993.tb12879.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  37 in total

1.  Coronary vasoconstriction in the conscious rabbit following intravenous infusion of L-NG-nitro-arginine.

Authors:  R G Humphries; R D Carr; A K Nicol; W Tomlinson; S E O'Connor
Journal:  Br J Pharmacol       Date:  1991-03       Impact factor: 8.739

2.  Isolation of nitric oxide synthetase, a calmodulin-requiring enzyme.

Authors:  D S Bredt; S H Snyder
Journal:  Proc Natl Acad Sci U S A       Date:  1990-01       Impact factor: 11.205

3.  A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.

Authors:  M M Bradford
Journal:  Anal Biochem       Date:  1976-05-07       Impact factor: 3.365

4.  Loss of vascular responsiveness induced by endotoxin involves L-arginine pathway.

Authors:  G Julou-Schaeffer; G A Gray; I Fleming; C Schott; J R Parratt; J C Stoclet
Journal:  Am J Physiol       Date:  1990-10

5.  The induction and suppression of prostaglandin H2 synthase (cyclooxygenase) in human monocytes.

Authors:  J Y Fu; J L Masferrer; K Seibert; A Raz; P Needleman
Journal:  J Biol Chem       Date:  1990-10-05       Impact factor: 5.157

6.  Control of regional blood flow by endothelium-derived nitric oxide.

Authors:  S M Gardiner; A M Compton; T Bennett; R M Palmer; S Moncada
Journal:  Hypertension       Date:  1990-05       Impact factor: 10.190

7.  NG-methyl-L-arginine inhibits tumor necrosis factor-induced hypotension: implications for the involvement of nitric oxide.

Authors:  R G Kilbourn; S S Gross; A Jubran; J Adams; O W Griffith; R Levi; R F Lodato
Journal:  Proc Natl Acad Sci U S A       Date:  1990-05       Impact factor: 11.205

8.  L-NG-nitro arginine (L-NOARG), a novel, L-arginine-reversible inhibitor of endothelium-dependent vasodilatation in vitro.

Authors:  P K Moore; O A al-Swayeh; N W Chong; R A Evans; A Gibson
Journal:  Br J Pharmacol       Date:  1990-02       Impact factor: 8.739

9.  Endothelial cells metabolize NG-monomethyl-L-arginine to L-citrulline and subsequently to L-arginine.

Authors:  M Hecker; J A Mitchell; H J Harris; M Katsura; C Thiemermann; J R Vane
Journal:  Biochem Biophys Res Commun       Date:  1990-03-30       Impact factor: 3.575

10.  The effect of indomethacin on the cardiovascular and metabolic responses to E. coli endotoxin in the cat.

Authors:  J R Parratt; R M Sturgess
Journal:  Br J Pharmacol       Date:  1974-02       Impact factor: 8.739

View more
  78 in total

1.  Regional haemodynamic responses to infusion of lipopolysaccharide in conscious rats: effects of pre- or post-treatment with glibenclamide.

Authors:  S M Gardiner; P A Kemp; J E March; T Bennett
Journal:  Br J Pharmacol       Date:  1999-12       Impact factor: 8.739

2.  Bacterial translocation in cirrhotic rats stimulates eNOS-derived NO production and impairs mesenteric vascular contractility.

Authors:  R Wiest; S Das; G Cadelina; G Garcia-Tsao; S Milstien; R J Groszmann
Journal:  J Clin Invest       Date:  1999-11       Impact factor: 14.808

3.  Calpain inhibitor I reduces the development of acute and chronic inflammation.

Authors:  S Cuzzocrea; M C McDonald; E Mazzon; D Siriwardena; I Serraino; L Dugo; D Britti; G Mazzullo; A P Caputi; C Thiemermann
Journal:  Am J Pathol       Date:  2000-12       Impact factor: 4.307

4.  Activation of the L-arginine nitric oxide pathway in severe sepsis.

Authors:  T Duke; M South; A Stewart
Journal:  Arch Dis Child       Date:  1997-03       Impact factor: 3.791

5.  Induction by endotoxin of nitric oxide synthase in the rat mesentery: lack of effect on action of vasoconstrictors.

Authors:  J A Mitchell; K L Kohlhaas; R Sorrentino; T D Warner; F Murad; J R Vane
Journal:  Br J Pharmacol       Date:  1993-05       Impact factor: 8.739

6.  Group B Streptococcus and E. coli LPS-induced NO-dependent hyporesponsiveness to noradrenaline in isolated intrapulmonary arteries of neonatal piglets.

Authors:  E Villamor; F Pérez-Vizcaíno; T Ruiz; J C Leza; M Moro; J Tamargo
Journal:  Br J Pharmacol       Date:  1995-05       Impact factor: 8.739

7.  Glibenclamide-induced inhibition of the expression of inducible nitric oxide synthase in cultured macrophages and in the anaesthetized rat.

Authors:  C C Wu; C Thiemermann; J R Vane
Journal:  Br J Pharmacol       Date:  1995-03       Impact factor: 8.739

8.  Delayed circulatory failure due to the induction of nitric oxide synthase by lipoteichoic acid from Staphylococcus aureus in anaesthetized rats.

Authors:  S J De Kimpe; M L Hunter; C E Bryant; C Thiemermann; J R Vane
Journal:  Br J Pharmacol       Date:  1995-03       Impact factor: 8.739

9.  Aminoguanidine attenuates the delayed circulatory failure and improves survival in rodent models of endotoxic shock.

Authors:  C C Wu; S J Chen; C Szabó; C Thiemermann; J R Vane
Journal:  Br J Pharmacol       Date:  1995-04       Impact factor: 8.739

10.  Co-induction of nitric oxide synthase and cyclo-oxygenase: interactions between nitric oxide and prostanoids.

Authors:  T A Swierkosz; J A Mitchell; T D Warner; R M Botting; J R Vane
Journal:  Br J Pharmacol       Date:  1995-04       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.